Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Market Cap	1.17T -6.7%
Revenue (ttm)	438.01B +4.9%
Net Income	153.56B +26.7%
EPS	7,142.41 +26.7%
Shares Out	21.50M
PE Ratio	7.62
Forward PE	n/a
Dividend	4,000.00 (7.35%)
Ex-Dividend Date	Mar 20, 2026

Volume	8,800
Average Volume	14,287
Open	55,000
Previous Close	55,100
Day's Range	54,200 - 55,000
52-Week Range	47,000 - 65,900
Beta	0.47
RSI	30.86
Earnings Date	Apr 17, 2026

About HNX:DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DP3

Financial Performance

In 2025, HNX:DP3's revenue was 438.01 billion, an increase of 4.92% compared to the previous year's 417.49 billion. Earnings were 153.56 billion, an increase of 26.73%.